已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Sinusoidal Obstruction Syndrom (SOS): Warning about Autologous Stem Cell Transplantation (ASCT) Preceded By Regimens Containing Oxaliplatin

医学 梅尔法兰 卡莫司汀 自体干细胞移植 外科 内科学 奥沙利铂 移植 肿瘤科 化疗 依托泊苷 癌症 结直肠癌
作者
Pierre-Édouard Debureaux,Delphine Le Febvre de Nailly,Emmanuelle Tavernier,Manel Bedoui,Frédérique Kuhnowski,Jérôme Tamburini,Luc Mathieu Fornecker,Hervé Tilly,David Sibon,Marie‐Pierre Moles,Sylvie Glaisner,Jean Philippe Richardet,Sebastien Mulé,Julien Caldéraro,Corinne Haı̈oun,Jehan Dupuis
出处
期刊:Blood [Elsevier BV]
卷期号:132 (Supplement 1): 4597-4597 被引量:1
标识
DOI:10.1182/blood-2018-99-110728
摘要

Abstract Introduction ASCT is a cornerstone in lymphoma therapeutics, especially in the relapse setting. BEAM (carmustine, etoposide, cytarabine, and melphalan) is the most widely used conditioning regimen with a low rate of transplant mortality. Bendamustine has occasionally been used in France as a substitute for carmustine during a period of shortage ("BendaEAM"). SOS is a potentially life-threatening complication, rarely observed in ASCT. In an EBMT study of 1010 ASCT, SOS occurred in less than 1% after BEAM in patients who had a normal level of AST before conditioning1. After having observed 5 cases of SOS in our institution during a 3 year period and numerous cases in other centers, we did perform a retrospective study in order to try to understand the apparent increase in incidence of this complication. Methods After a national alert spread through our cooperative group (LYSA) and the French health agency (ANSM), we collected history of lymphoma, hepatic disease, chemotherapy, SOS risks factor, conditioning of ASCT, diagnostic criteria for SOS (based on the EBMT classification2 or liver biopsy), treatment and outcomes. We did determine the incidence in 2 centers (Henri Mondor University Hospital and Curie Institute) where the total number of ASCT was available. Results We observed 6 cases of SOS after ASCT in Henri Mondor University Hospital during the last 10 years (incidence 4.1% on 145 ASCT for lymphoma) among which the 5 most recent cases had oxaliplatin exposure before ASCT. Oxaliplatin exposition tended to be associated with SOS (p=0.09). In Curie Institute, a SOS incidence of 3/46 (6.5%) was reported during a 6 year-period, and all three patients had received oxaliplatin before ASCT. A national query permitted to find 22 cases of SOS in 10 centers during the last 6 years. Twenty had a history of oxaliplatine exposure before ASCT. Principal characteristics are presented in table 1. No patient had a history of cirrhosis or significant hepatic pathology. Two patients had liver infiltration due to the lymphoma before treatment by oxaliplatin. The majority of patients didn't present with any of the known risk factors for SOS. One patient had liver anomalies (AST > 2 ULN and cholestasis) after 4 cycles of an oxaliplatin-containing regimen for relapsing diffuse large B-cell lymphoma. Biopsy of liver showed early sinusoidal lesions. Despite these results, he proceeded to ASCT with BEAM conditioning and experimented a moderate form of SOS. Five patients received fluconazole and aprepitant during conditioning. Discussion During the last decade, cisplatin was often substituted by oxaliplatin inside the DHAP protocol in order to avoid renal impairment. Pre-operative oxaliplatin in hepatic metastases of colorectal cancer leads to asymptomatic damage of sinusoidal endothelial cells (SEC) in half of the patients3. Our principal hypothesis is that oxaliplatin provokes a frailty of liver and conditioning of ASCT and co-factors (peg-filgrastim and cytochromes inhibitors- fluconazole and aprepitant) lead to SOS. SEC had a receptor for G-CSF and activation of this receptor lead to inflammatory state4. Peg-filgrastim administered at a fixed dose in the early time of ASCT (Day+1 or +3) with low concurrence increases the inflammatory state of SEC. Fluconazole and aprepitant are inhibitors of cytochromes 3A4 which metabolize etoposide. Each inhibitor could increase exposition to etoposide. Five patients received both inhibitors during conditioning which might have increased liver toxicity which led to SOS. Conclusion We want to warn about the probable association of oxaliplatin before ASCT and SOS. In some French centers, this led to switch oxaliplatin by carboplatin for patients eligible to ASCT. BibliographyCarreras E et al. Incidence and outcome of hepatic VOD after blood or marrow transplantation: a prospective cohort study of the EBMT. Blood. 1998;92(10):3599-3604.Mohty M et al. Revised diagnosis and severity criteria for SOS/VOD in adult patients: a new classification from the EBMT. Bone Marrow Transplant. 2016;51(7):906-912.Rubbia-Brandt L et al. Severe SOS associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol. 2004;15(3):460-466.Fusté B et al. GSF factor increases expression of adhesion receptors on endothelial cells through activation of p38 MAPK. Haematologica, 2004;8. Table 1. Table 1. Disclosures Tilly: Astra-Zeneca: Membership on an entity's Board of Directors or advisory committees; Karyopharm: Membership on an entity's Board of Directors or advisory committees; Roche: Membership on an entity's Board of Directors or advisory committees; Celgene: Membership on an entity's Board of Directors or advisory committees; BMS: Honoraria. Haioun:Janssen: Consultancy, Honoraria; Celgene: Consultancy, Honoraria; Gilead Sciences: Consultancy, Honoraria; Amgen: Consultancy, Honoraria; Roche: Consultancy, Honoraria; Takeda: Consultancy, Honoraria; Sciences: Consultancy, Honoraria.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小湛完成签到 ,获得积分10
1秒前
菜根谭完成签到 ,获得积分10
1秒前
董羽佳完成签到,获得积分10
13秒前
KobeLaoda完成签到,获得积分10
15秒前
吃的饭广泛完成签到 ,获得积分0
16秒前
薛wen晶完成签到 ,获得积分10
19秒前
19秒前
CC发布了新的文献求助30
21秒前
Owen应助oleskarabach采纳,获得10
24秒前
orixero应助长琴思顾采纳,获得10
27秒前
Maryamgvl完成签到 ,获得积分10
30秒前
小鲤鱼吃大菠萝完成签到,获得积分10
31秒前
荀万声完成签到,获得积分10
33秒前
绝对草草完成签到,获得积分10
33秒前
Georgechan完成签到,获得积分10
33秒前
33秒前
珂珂完成签到 ,获得积分10
35秒前
辛夷完成签到,获得积分10
36秒前
37秒前
大模型应助科研通管家采纳,获得10
37秒前
夏风下发布了新的文献求助10
37秒前
38秒前
共享精神应助读书的时候采纳,获得10
39秒前
研友_VZG7GZ应助读书的时候采纳,获得10
39秒前
无花果应助读书的时候采纳,获得30
39秒前
CodeCraft应助读书的时候采纳,获得10
39秒前
CodeCraft应助读书的时候采纳,获得10
39秒前
汉堡包应助读书的时候采纳,获得10
39秒前
上官若男应助读书的时候采纳,获得10
39秒前
我是老大应助读书的时候采纳,获得10
39秒前
42秒前
45秒前
长琴思顾发布了新的文献求助10
47秒前
48秒前
超级的代柔完成签到 ,获得积分10
52秒前
刘雪完成签到 ,获得积分10
54秒前
小刘完成签到,获得积分10
57秒前
小HO完成签到 ,获得积分10
1分钟前
wang5945完成签到 ,获得积分10
1分钟前
景行行止完成签到 ,获得积分10
1分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989989
求助须知:如何正确求助?哪些是违规求助? 3532034
关于积分的说明 11256053
捐赠科研通 3270900
什么是DOI,文献DOI怎么找? 1805105
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809216